BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31744508)

  • 1. Genetic dynamics in untreated CLL patients with either stable or progressive disease: a longitudinal study.
    Ramassone A; D'Argenio A; Veronese A; Basti A; Soliman SHA; Volinia S; Bassi C; Pagotto S; Ferracin M; Lupini L; Saccenti E; Balatti V; Pepe F; Rassenti LZ; Innocenti I; Autore F; Marzetti L; Mariani-Costantini R; Kipps TJ; Negrini M; Laurenti L; Visone R
    J Hematol Oncol; 2019 Nov; 12(1):114. PubMed ID: 31744508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of clonal evolution in chronic lymphocytic leukemia.
    Koczkodaj D; Popek-Marciniec S; Zmorzyński S; Wąsik-Szczepanek E; Filip AA
    Med Oncol; 2019 Aug; 36(9):79. PubMed ID: 31375939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival.
    Stilgenbauer S; Sander S; Bullinger L; Benner A; Leupolt E; Winkler D; Kröber A; Kienle D; Lichter P; Döhner H
    Haematologica; 2007 Sep; 92(9):1242-5. PubMed ID: 17666364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia.
    Leeksma AC; Taylor J; Wu B; Gardner JR; He J; Nahas M; Gonen M; Alemayehu WG; Te Raa D; Walther T; Hüllein J; Dietrich S; Claus R; de Boer F; de Heer K; Dubois J; Dampmann M; Dürig J; van Oers MHJ; Geisler CH; Eldering E; Levine RL; Miller V; Mughal T; Lamanna N; Frattini MG; Heaney ML; Zelenetz A; Zenz T; Abdel-Wahab O; Kater AP
    Leukemia; 2019 Feb; 33(2):390-402. PubMed ID: 30038380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenografts.
    Davies NJ; Kwok M; Gould C; Oldreive CE; Mao J; Parry H; Smith E; Agathanggelou A; Pratt G; Taylor AMR; Moss P; Griffiths M; Stankovic T
    Oncotarget; 2017 Jul; 8(27):44749-44760. PubMed ID: 28496009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD markers variations in chronic lymphocytic leukemia: New insights into prognosis.
    Vosoughi T; Bagheri M; Hosseinzadeh M; Ehsanpour A; Davari N; Saki N
    J Cell Physiol; 2019 Nov; 234(11):19420-19439. PubMed ID: 31049958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia.
    Ojha J; Ayres J; Secreto C; Tschumper R; Rabe K; Van Dyke D; Slager S; Shanafelt T; Fonseca R; Kay NE; Braggio E
    Blood; 2015 Jan; 125(3):492-8. PubMed ID: 25377784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOHO State of the Art Updates and Next Questions: Clonal Evolution in Chronic Lymphocytic Leukemia.
    Condoluci A; Rossi D
    Clin Lymphoma Myeloma Leuk; 2020 Dec; 20(12):779-784. PubMed ID: 33039357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared clonal IGH rearrangement in BCP-ALL occurring after CLL: pitfalls and implications for MRD monitoring.
    Derrieux C; Gish A; Caulier A; Grardel N; Garidi R; Joris M; Assouan D; Poulain S; Decool G; Ferret Y; Caillault-Venet A; Marolleau JP; Preudhomme C; Boyer T
    Br J Haematol; 2020 Nov; 191(3):506-509. PubMed ID: 32754904
    [No Abstract]   [Full Text] [Related]  

  • 10. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
    He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
    Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia.
    Ouillette P; Saiya-Cork K; Seymour E; Li C; Shedden K; Malek SN
    Clin Cancer Res; 2013 Jun; 19(11):2893-904. PubMed ID: 23620403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of altered cell signaling pathways using proteomic profiling in stable and progressive chronic lymphocytic leukemia.
    Bagacean C; Iuga CA; Bordron A; Tempescul A; Pralea IE; Bernard D; Cornen M; Bergot T; Le Dantec C; Brooks W; Saad H; Ianotto JC; Pers JO; Zdrenghea M; Berthou C; Renaudineau Y
    J Leukoc Biol; 2022 Feb; 111(2):313-325. PubMed ID: 34288092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia.
    Amin NA; Seymour E; Saiya-Cork K; Parkin B; Shedden K; Malek SN
    Clin Cancer Res; 2016 Sep; 22(17):4525-35. PubMed ID: 27060156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase.
    Hernández-Sánchez M; Kotaskova J; Rodríguez AE; Radova L; Tamborero D; Abáigar M; Plevova K; Benito R; Tom N; Quijada-Álamo M; Bikos V; Martín AÁ; Pal K; García de Coca A; Doubek M; López-Bigas N; Hernández-Rivas JM; Pospisilova S
    Leukemia; 2019 Feb; 33(2):518-558. PubMed ID: 30209402
    [No Abstract]   [Full Text] [Related]  

  • 15. High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature.
    Janssens A; Van Roy N; Poppe B; Noens L; Philippé J; Speleman F; Offner F
    Eur J Haematol; 2012 Jul; 89(1):72-80. PubMed ID: 22509718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal evolution in chronic lymphocytic leukemia: impact of subclonality on disease progression.
    Sutton LA; Rosenquist R
    Expert Rev Hematol; 2015 Feb; 8(1):71-8. PubMed ID: 25345442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathogenesis of CLL and its evolution.
    Rodríguez D; Bretones G; Arango JR; Valdespino V; Campo E; Quesada V; López-Otín C
    Int J Hematol; 2015 Mar; 101(3):219-28. PubMed ID: 25630433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience.
    Spunarova M; Tom N; Pavlova S; Mraz M; Brychtova Y; Doubek M; Panovska A; Skuhrova Francova H; Brzobohata A; Pospisilova S; Mayer J; Trbusek M
    Leuk Res; 2019 Jun; 81():75-81. PubMed ID: 31054420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary abnormalities of chromosome 6q in B-cell chronic lymphocytic leukemia: a sequential study of karyotypic instability in 51 patients.
    Finn WG; Kay NE; Kroft SH; Church S; Peterson LC
    Am J Hematol; 1998 Nov; 59(3):223-9. PubMed ID: 9798660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene mutations in chronic lymphocytic leukemia.
    Amin NA; Malek SN
    Semin Oncol; 2016 Apr; 43(2):215-21. PubMed ID: 27040699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.